CLINICAL SUPPLY MANUFACTURING ARTICLES

image001-(5) A Phase-Appropriate Approach For Assay Validation In Cell & Gene Therapies

This article promotes alignment on a common phase-appropriate approach to analytical assay validation with respect to the critical quality attributes of the most common cell/gene therapy modalities. 

CLINICAL SUPPLY MANUFACTURING VIDEOS

Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

Susan Dexter, Chief Technical Officer, Sonnet BioTherapeutics, describes the good choices she made, and one not-so-good choice, in trying to untie a knotted supply chain.

Tony Sampognaro, Director, CMC Project Management, Stoke Therapeutics, recalls a rather harrowing experience involving a CMO and Clinical Operations failure to communicate.

If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

CLINICAL SUPPLY MANUFACTURING RESOURCES